Investors are shifting their focus to established medtech companies with FDA-cleared products, while some early-stage ...
14h
Dealbreaker on MSNBuilding Solid Relationships with Universities Critical for Early Stage Medtech InvestorsIn a Q&A Jenni Le, a principal and investor with Venture Investors Health Fund, and INVEST Pitch Perfect judge, talked about ...
13h
Barchart on MSNIs Johnson & Johnson Stock Underperforming the Dow?With a market cap of $394.2 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company ...
The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for ...
As the medical technology space reaches close to $600 billion in the U.S. alone, Freudenberg Medical and its original ...
10don MSN
Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for ...
Citi’s 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ETCompany ParticipantsPreston Wells ...
After hundreds of FDA employees were suddenly laid off last weekend, including dozens at the agency’s device center, the ...
Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may ...
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Anupam Girdhar, divisional CEO of Ascential Medical & Life Sciences, discusses the role of digitalization in shaping MedTech ...
Thermo Fisher Scientific plans to acquire Solventum's Purification and Filtration business for $4.1 billion in cash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results